Evidence map›Paper›PMID 28355205›Full record

ArticlePediatric research2017

Interaction between maternal caffeine intake during pregnancy and CYP1A2 C164A polymorphism affects infant birth size in the Hokkaido study.

Seiko Sasaki, Mariko Limpar, Fumihiro Sata, Sumitaka Kobayashi, Reiko Kishi

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Maternal Caffeine Consumption and Pregnancy Outcomes.Advances in experimental medicine and biology · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Neuroprotective Effects of Coffee Bioactive Compounds: A Review.International journal of molecular sciences · 2020
    Review
  14. Impacts of Caffeine during Pregnancy.Trends in endocrinology and metabolism: TEM · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Seiko SasakiDepartment of Public Health Sciences, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Mariko LimparDepartment of Public Health Sciences, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Fumihiro SataHealth Center, Chuo University, Tokyo, Japan.
Sumitaka KobayashiHokkaido University Center for Environmental and Health Sciences, Sapporo, Japan.
Reiko KishiHokkaido University Center for Environmental and Health Sciences, Sapporo, Japan.
Hokkaido Institute of Public Health · JPChuo University · JPHokkaido University · JPSapporo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundCaffeine, 1,3,7-trimethylxanthine, is widely consumed by women of reproductive age. Although caffeine has been proposed to inhibit fetal growth, previous studies on the effects of caffeine on infant birth size have yielded inconsistent findings. This inconsistency may result from failure to account for individual differences in caffeine metabolism related to polymorphisms in the gene for CYP1A2, the major caffeine-metabolizing enzyme.MethodsFive hundred fourteen Japanese women participated in a prospective cohort study in Sapporo, Japan, from 2002 to 2005, and 476 mother-child pairs were included for final analysis.ResultsCaffeine intake was not significantly associated with mean infant birth size. When caffeine intake and CYP1A2 C164A genotype were considered together, women with the AA genotype and caffeine intake of ≥300 mg per day had a mean reduction in infant birth head circumference of 0.8 cm relative to the reference group after adjusting for confounding factors. In a subgroup analysis, only nonsmokers with the AA genotype and caffeine intake of ≥300 mg per day had infants with decreased birth weight (mean reduction, 277 g) and birth head circumference (mean reduction, 1.0 cm).ConclusionNonsmokers who rapidly metabolize caffeine may be at increased risk for having infants with decreased birth size when consuming ≥300 mg of caffeine per day.

Indexed as

Birth WeightMaternal ExposurePolymorphism, Single NucleotideAlcohol DrinkingCaffeineCohort StudiesCytochrome P-450 CYP1A2FemaleGenotypeHumansInfant, Low Birth WeightInfant, NewbornJapanMaleMaternal AgePregnancyCaffeineCYP1A2 protein, humanCytochrome P-450 CYP1A2

Identifiers

PMID28355205
OpenAlexW2599601489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.